Brief: Bio Path Holdings, On March 8, Regained Compliance With Nasdaq's Minimum Bid Price Requirement
11/03/2024 11:56
March 11 (Reuters) - Bio Path Holdings Inc BPTH.O :
* BIO PATH HOLDINGS - ON MARCH 8, RECEIVED LETTER FROM
NASDAQ
NOTIFYING CO THAT IT HAS REGAINED COMPLIANCE WITH MINIMUM BID
PRICE REQUIREMENT
Source text for Eikon: ID:n0001558370-24-002853
Further company coverage: BPTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Path Holdings
See all newsBrief: Bio-Path Holdings Seeks Financing For Turnaround & Strategic Actions
Brief: Bio-Path Holdings Reports Full Year 2024 Financial Results
Brief: Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Brief: Bio-Path Provides Key Clinical Updates
Brief: Bio-Path Holdings Provides Update From Phase 1/1B Clinical Trial Of Bp1002 For Treatment Of Refractory/Relapsed Acute Myeloid Leukemia